Tissue Factor and Tissue Factor Pathway Inhibitor in Chronically Inflamed Gallbladder Mucosa

Table 2

Number (percentage) of patients studied within each of TF and TFPI scores and mean number of CD68 and CD3 positive cells.

Haemostasis and cell markers studied	Score	Control n = 16	Cholecystitis n = 54	𝑃^∗
TF, n (%)	≤1+	15 (93.7)	15 (27.8)	<.001
	2+	1 (6.3)	15 (27.8)
	3+	0 (0)	24 (44.4)
TFPI, n (%)	≤1+	2 (12.5)	31 (57.4)	<.001
	2+	13 (81.2)	15 (27.8)
	3+	1 (6.3)	8 (14.8)
CD3+, mean ± SD	—	3.1 ± 1.9	18.6 ± 12.2	<.001
CD68, mean ± SD	—	8.8 ± 3.9	29.7 ± 13.9	<.001

∗Cholecystitis group versus control.